Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Syngene InternationalNSE:SYNGENE -3.33%86 Days Inventory is 74.36 as of Jun. 2026, which is 30% above its 10-year median of 57.37. GuruFocus rates NSE:SYNGENE with a GF Score™ of 86/100 and a GF Value™ of ₹730.78 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 178 Medical Diagnostics & Research companies, Syngene International ranks better than 51.12% on this metric.
The historical rank and industry rank for Syngene International's Days Inventory or its related term are showing as below:
NSE:SYNGENE'
s Days Inventory Range Over the Past 10 Years
Min: 24.1 Med: 57.37 Max: 112.09
Current: 67.64
During the past 13 years, Syngene International's highest Days Inventory was 112.09. The lowest was 24.10. And the median was 57.37.
NSE:SYNGENE's Days Inventory is ranked better than 51.12% of 178
companies
in the Medical Diagnostics & Research industry
Industry Median: 67.04
vs NSE:SYNGENE: 67.64
Inventory Turnover measures how fast the company turns over its inventory within a year.
Syngene International's Inventory Turnover for the
three
months ended in Jun. 2026 was 1.23.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Syngene International's Inventory-to-Revenue for the
three
months ended in Jun. 2026 was 0.19.
Syngene International (NSE:SYNGENE) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Syngene International's Inventory Turnover for the
three
months ended in Jun. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Syngene International's Inventory to Revenue for the
three
months ended in Jun. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Syngene International Days Inventory Related Terms
Syngene International Days Inventory Historical Data
* Premium members only.
The historical data trend for Syngene International's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:SYNGENE vs TMO, DHR, IDXX: Days Inventory Comparison
For the Diagnostics & Research subindustry, Syngene International's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Syngene International Days Inventory vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Syngene International's Days Inventory distribution charts can be found below:
* The bar in red indicates where Syngene International's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Syngene International (NSE:SYNGENE) has a Days Inventory of 74.36 as of Jun. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Syngene International and its competitors. This is 30% above median its historical median of 57.37. Over the past decade, Syngene International's Days Inventory has ranged from 24.10 to 112.09. According to the industry distribution chart, Syngene International ranks #87 out of 178 companies in the Medical Diagnostics & Research industry, placing it in the top 48.9%.
Is Syngene International's Days Inventory too high?
Syngene International's current Days Inventory of 74.36 is 30% above median its 10-year median of 57.37. Over the past 10 years, this metric has ranged from a low of 24.10 to a high of 112.09. The Medical Diagnostics & Research industry median Days Inventory is 67.04. Syngene International's value of 74.36 is 10.9% above this industry median. Based on the distribution chart, Syngene International ranks #87 out of 178 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Syngene International has a GF Score™ of 86/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Syngene International's Days Inventory compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Syngene International ranks #87 out of 178 companies for Days Inventory. This puts Syngene International in the upper half of its industry. The industry median Days Inventory is 67.04. Syngene International's value of 74.36 is 10.9% above this benchmark. Historically, Syngene International's own Days Inventory has ranged from 24.10 to 112.09 over the past decade. While the company's 10-year median is 57.37 vs. the industry median of 67.04, Syngene International has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Diagnostics & Research company?
The median Days Inventory among Medical Diagnostics & Research companies is 67.04, based on 178 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Syngene International's current Days Inventory of 74.36 is 10.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Syngene International and its competitors. For the Medical Diagnostics & Research industry, the median Days Inventory is 67.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Syngene International's current Days Inventory is 74.36, which is 30% above median its own 10-year median of 57.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Syngene International stock overvalued right now?
Based on GuruFocus' analysis, Syngene International (NSE:SYNGENE) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹730.78, compared to a current price of ₹385.90 — trading 47.2% below its estimated fair value. The current Days Inventory is 74.36, which is 30% above median its 10-year median of 57.37 and 10.9% above the Medical Diagnostics & Research industry median of 67.04. Syngene International's overall GF Score™ is 86/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Syngene International (NSE:SYNGENE), the current Days Inventory is 74.36 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Syngene International (NSE:SYNGENE) Overvalued in 2026?
Based on GuruFocus' analysis, Syngene International stock appears to be undervalued.
The current stock price of ₹385.90 is trading 47.2% below its estimated GF Value™ of ₹730.78.
GuruFocus considers Syngene International to be Significantly Undervalued.
Key valuation signals for NSE:SYNGENE:
Days Inventory: 74.36 (30% above median its 10-year median of 57.37)
GF Value™: ₹730.78 vs. price of ₹385.90 (47.2% below fair value)
Industry Position: 10.9% above the Medical Diagnostics & Research median (#87 of 178)
No single metric tells the full story. See the NSE:SYNGENE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Syngene International Ltd is a contract research and manufacturing organization in India. It supports research and development programs, from lead generation to clinical and commercial supplies. The Company is engaged in a single operating segment of providing contract research and manufacturing services. The company operates in India, the United States of America and other countries, of which a majority of the revenue is derived from the USA. The company receives revenue by providing contract research and manufacturing services. It offers services such as Oligonucleotide synthesis, Bioinformatics, Clinical development services, polymer research, chemical development, safety assessment, discovery chemistry, discovery biology, and others.
86GF Score
Get the complete analysis for NSE:SYNGENE
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SYNGENE has been successfully added to your 
